PATENT CLAIM ANALYSIS

Application Number: 16083865
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "637000"]

Abstract:
An ophthalmic composition or dosage form can include a therapeutically effective amount of a cross-linking agent and a pharmaceutically acceptable carrier. The composition or dosage form can be used to treat an ophthalmic condition by administering a therapeutically effective amount of the composition to an eye of a subject during a treatment period.

Claim (Index 3):
The composition of  claim 1 , wherein the cross-linking agent comprises a copper-containing agent.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 97.0
- Lexical Diversity: 1.57143
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13665495', '13387668', '13480127', '15570016', '12315829']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7191111152649036
- 35 USC 102 Novelty (BERT): 0.4951491851056359
- Combined Prediction Score: 0.6967149222489768
- Mean Citation Score: 180.467596
- Max Citation Score: 190.64987
- Similarity Product: 123.65696820688068

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test